251 results on '"Mulak, Agata"'
Search Results
2. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
3. Small intestinal bacterial overgrowth in Alzheimer’s disease
4. Microbiota medicine: towards clinical revolution
5. Impact of Primary and Secondary Bile Acids on Clostridioides difficile Infection
6. A correlation of serum fibroblast growth factor 21 level with inflammatory markers and indicators of nutritional status in patients with inflammatory bowel disease.
7. Serum fibroblast growth factor 19 level correlates inversely with clinical and endoscopic activity of inflammatory bowel disease
8. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
9. Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice
10. Sex hormones in the modulation of irritable bowel syndrome
11. Work productivity and activity impairment in disorders of gut-brain interaction:Data from the Rome Foundation Global Epidemiology Study
12. Stress-Related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study
13. Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
14. Face‐to‐face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population‐based research
15. Thyrotropin Releasing Hormone Agonist, Rx-77368, Injected Intracerebroventricularly and Acute Cold Exposure: Analgesic Effect on Nociception Induced by Colorectal Distension in Conscious Male Rats
16. Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?
17. Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure
18. Faculty Opinions recommendation of Review article: Exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome.
19. A controversy on the role of short‐chain fatty acids in the pathogenesis of Parkinsonʼs disease
20. Sex‐ and gender‐related differences in the prevalence and burden of disorders of gut‐brain interaction in Poland.
21. Mo1599: AN INCREASED SERUM FIBROBLAST GROWTH FACTOR 19 LEVEL AS A MARKER OF BILE ACID SIGNALING ALTERATIONS IN PARKINSON’S DISEASE
22. Sa1192: MANAGEMENT OF REFRACTORY GERD SYMPTOMS IN EUROPE: EXPERT OPINION IN A CASE-BASED DELPHI APPROACH
23. Sexual Dimorphism in the Gut Microbiome: Microgenderome or Microsexome?
24. Su1915 RIFAXIMIN MODULATES SEVERITY OF SYMPTOMS OF PARKINSON'S DISEASE WITH CONCOMITANT SMALL INTESTINAL BACTERIAL OVERGROWTH
25. Tu1166 IMPACT OF ECONOMIC AND PSYCHOSOCIAL FACTORS ON SYMPTOM SEVERITY IN PATIENTS WITH DISORDERS OF GUT-BRAIN INTERACTION DURING THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW AND META-ANALYSIS
26. Tu1030 A MULTIFACETED ECOLOGICAL APPROACH TO EXPLORE LINKS BETWEEN ENVIRONMENTAL FACTORS AND THE EPIDEMIOLOGY OF DISORDERS OF GUT-BRAIN INTERACTION
27. The impact of eating behavior and emotional state on the severity of IBS symptoms
28. Stress and visceral pain: From animal models to clinical therapies
29. Physiological and pathophysiological role of endocrine fibroblast growth factors
30. Small intestinal bacterial overgrowth in Alzheimer’s disease
31. Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study
32. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
33. Lessons learned — resolving the enigma of genetic factors in IBS
34. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
35. Anorectal function and dyssynergic defecation in different subgroups of patients with irritable bowel syndrome
36. The impact of probiotics on interactions within the microbiota-gut-lung triad in COVID-19
37. European Society for Neurogastroenterology and Motility recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID‐19 pandemic
38. Faculty Opinions recommendation of Impact of tonsillectomy on irritable bowel syndrome: A nationwide population-based cohort study.
39. Modulation of Visceral Pain by Stress: Implications in Irritable Bowel Syndrome
40. Psychological Stress Induces Visceral Analgesic or Hyperalgesic Response in Rodents: A Role of Preconditions
41. Recent Data on Irritable Bowel Syndrome from some Central and East European Countries
42. An Inverse Correlation of Serum Fibroblast Growth Factor 19 with Abdominal Pain and Inflammatory Markers in Patients with Ulcerative Colitis
43. 273 PREVALENCE AND IMPACT OF FUNCTIONAL DYSPEPSIA ACCORDING TO THE ROME IV DEFINITIONS IN A GLOBAL EPIDEMIOLOGICAL SURVEY
44. 405 ROME IV AND ROME III IRRITABLE BOWEL SYNDROME (IBS) ACROSS THE GLOBE: FINDINGS OF A POPULATION-BASED INTERNET SURVEY OF ADULTS IN 26 COUNTRIES
45. Faculty Opinions recommendation of Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
46. An overview of the neuroendocrine system in Parkinson’s disease: what is the impact on diagnosis and treatment?
47. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.
48. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease
49. Mo1832 – An Inverse Correlation of Serum Fibroblast Growth Factor 19 with Abdominal Pain and Inflammatory Markers in Patients with Ulcerative Colitis
50. Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.